Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Contrave
Contrave
FDA Rejection Would Take Isis Stock Down
Seeking Alpha
Thu, 02/3/11 - 11:47 am
FDA
mipomersen
Orexigen
Contrave
Isis Pharmaceuticals
Heart Study Could Cost Twice Orexigen’s Market Cap
Forbes
Wed, 02/2/11 - 08:44 am
Orexigen
obesity
Contrave
Obesity Drugs: The Road to Perdition
TheStreet.com
Tue, 02/1/11 - 11:22 am
obesity
Orexigen
Vivus
Arena Pharmaceuticals
Contrave
Qnexa
Lorqess
Orexigen: 'Bad' Rejection of Obesity Drug
TheStreet.com
Tue, 02/1/11 - 08:19 am
FDA
Orexigen
Contrave
obesity
Orexigen shares jump ahead of FDA decision
Marketwatch
Mon, 01/31/11 - 11:53 am
FDA
Contrave
Orexigen
Biotech Stock Mailbag: Orexigen Therapeutics
TheStreet.com
Fri, 01/28/11 - 12:13 pm
Orexigen
Contrave
Arena Pharmaceuticals
Vivus
Avanir
Discovery Labs
Cel-Sci
Trading Orexigen's PDUFA Event
Seeking Alpha
Thu, 01/27/11 - 09:38 pm
Orexigen
PDUFA
Contrave
Eight Factors That May Impact Approval of Orexigen's Weight Loss Drug
Seeking Alpha
Thu, 01/20/11 - 09:55 am
Orexigen
obesity
Contrave
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Orexigen Approval Shows That Diversification Strategy Can Work
Seeking Alpha
Thu, 12/9/10 - 10:55 am
Orexigen
FDA
Contrave
Diet Drug Rally: Orexigen, Vivus, Arena
TheStreet.com
Wed, 12/8/10 - 12:27 pm
obesity
Orexigen
Vivus
Arena Pharmaceuticals
Contrave
Qnexa
Orexigen Wins U.S. Panel’s Backing for New Diet Pill
Bloomberg Businessweek
Tue, 12/7/10 - 06:05 pm
obesity
Orexigen
advisory panels
FDA
Contrave
Orexigen Therapeutics: FDA Panel Live Blog
TheStreet.com
Tue, 12/7/10 - 07:56 am
FDA
advisory panels
Orexigen
Contrave
obesity
Orexigen braces for advisory panel's Contrave review
Fierce Biotech
Mon, 12/6/10 - 05:04 pm
Orexigen
Contrave
FDA
advisory panels
obesity
Advisory Votes Against Expanding Use of GSK’s, Merck’s Prostate Drugs: Biotech's Latest Tribulations
Seeking Alpha
Sun, 12/5/10 - 11:52 am
GSK
Merck
Avodart
enlarged prostate
prostate cancer
Proscar
Orexigen
obesity
Contrave
Novartis
JNJ
Merck KGaA
FDA: Proposed Weight Loss Drug Contrave Raises Blood Pressure
WSJ
Sat, 12/4/10 - 12:33 pm
Takeda
Contrave
weight loss
obesity. Orexigen Therapeutics
FDA: Proposed Weight Loss Drug Contrave Raises Blood Pressure
WSJ Online
Fri, 12/3/10 - 11:06 am
FDA
obesity
Contrave
hypertension
Orexigen
Orexigen's Diet Pill Has Unclear Benefits, an FDA Staff Review Indicates
Bloomberg
Fri, 12/3/10 - 08:46 am
Orexigen
FDA
Contrave
obesity
Orexigen: Don't Count Contrave Out Yet
Seeking Alpha
Fri, 12/3/10 - 06:45 am
FDA
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Vivus
Orexigen Options Suggest Contrave Diet Pill May Avoid Arena, Vivus Delays
Bloomberg
Thu, 12/2/10 - 10:17 am
Orexigen
options
Contrave
obesity
Vivus
Arena Pharmaceuticals
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »